Skip to main content
OpenTrials

Clinical trial condition

Muscular Disorders, Atrophic

Explore clinical trials studying Muscular Disorders, Atrophic. Study availability and eligibility vary by location and protocol.

621 public trials 123 recruiting studies
Refine in advanced search Browse all conditions

Muscular Disorders, Atrophic trial results

Enrolling by Invitation

An Observational Study Comparing Delandistrogene Moxeparvovec (ELEVIDYS) With Standard of Care in Participants With Duchenne Muscular Dystrophy

NCT06270719

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Duchenne Muscular Dystrophy, Genetic Diseases, Inborn, +8 more
Locations
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • Children's Hospital Los Angeles - PIN Los Angeles, California, United States
  • University of Colorado - PPDS Aurora, Colorado, United States
  • Connecticut Children's Medical Center - Hartford Hartford, Connecticut, United States
View all 25 locations
View Trial Details
Enrolling by Invitation

Long Term Follow-up for RGX-202

NCT06491927

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Duchenne Muscular Dystrophy, Genetic Diseases, Inborn, +8 more
Locations
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • Stanford School of Medicine /Division of Neuromuscular Medicine Palo Alto, California, United States
  • Ann & Robert H. Lurie Children's Hospital of Chicago Chicago, Illinois, United States
  • The University of Texas Southwestern Medical Center Dallas, Texas, United States
View Trial Details
Enrolling by Invitation

Open-Label Extension Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy

NCT07209332

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Duchenne Muscular Dystrophy, Genetic Diseases, Inborn, +8 more
Locations
  • Istiklal Hospital/ Clinical Research Unit Amman, Jordan
  • The Specialty Hospital (TSH)/ Advanced Clinical Center Amman, Jordan
  • Oxford Children's Hospital, Oxford University Hospitals NHS Foundation Trust Headington, Oxford, United Kingdom
View Trial Details
Enrolling by Invitation

A Long-term Follow-up Study of Participants Who Received Delandistrogene Moxeparvovec (SRP-9001) in a Previous Clinical Study

NCT05967351

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Duchenne Muscular Dystrophy, Genetic Diseases, Inborn, +8 more
Locations
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • UCLA Medical Center Los Angeles, California, United States
  • Lucile Packard Children's Hospital Stanford (LPCH) Palo Alto, California, United States
  • University of California, Davis Sacramento, California, United States
View all 38 locations
View Trial Details
Enrolling by Invitation

An Open-Label Extension Study to Evaluate the Long-Term Safety and Efficacy of Once Daily Mexiletine PR in Patients With Myotonic Dystrophy Type 1 and Type 2 Who Have Completed MEX-DM-302 Study.

NCT06549400

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +9 more
Locations
  • Laboratory for Muscle Diseases and Neuropathies Leuven, Belgium
  • Aarhus University Hospital Aarhus, Denmark
  • Ludug-Maximilians University München, Germany
  • Azienda Ospedaliera Universitaria Policlinico Tor Vergata Rome, Italy
View Trial Details

Related conditions